Ç㼺Çõ ¸íÀÇ

³úÁ¹Áß Ä¡·áÀÇ ÆÄ¼ö²Û, °ñµçŸÀÓ ÁöÅ´ÀÌ

Ç㼺Çõ ¸íÀÇ

  • ¼Ò ¼Ó
    °æÈñ´ëÇб³º´¿ø
  • Áø·á°ú
    ½Å°æ°ú
  • Àü¹®ºÐ¾ß
    ³úÁ¹Áß, ³úÇ÷°üÁúȯ, µÎÅë

³úÁ¹Áß Áø´Ü°ú Ä¡·á ºÐ¾ßÀÇ ±ÇÀ§ÀÚ·Î ÀÎÁ¤¹Þ´Â Ç㼺Çõ ±³¼ö´Â ±Þ¼º±â ³úÁ¹Áß È¯ÀÚÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á¿¡¼­ ¶Ù¾î³­ ¼º°ú¸¦ º¸À̰í ÀÖ´Ù. ÃֽгúÁ¹Áß Ä¡·á¹ý °³¹ß ¹× Àû¿ë¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ȯÀÚ ¸ÂÃãÇü ÀçȰ ÇÁ·Î±×·¥À» ÅëÇØ ³úÁ¹Áß ÈÄÀ¯Áõ °¨¼Ò¿¡ ±â¿©Çϰí ÀÖ´Ù. ´ÙÇÐÁ¦Àû Á¢±ÙÀ¸·Î ³úÁ¹ÁßÀÇ ¿¹¹æºÎÅÍ ÀçȰ±îÁö Á¾ÇÕÀû °ü¸®¸¦ ¼±µµÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °æÈñ´ë ÀÇ´ë Çлç
  • °æÈñ´ë ÀÇ´ë ¼®»ç
  • °æÈñ´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³º´¿ø ½Å°æ°ú ±³¼ö

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѰíÇ÷¾ÐÇÐȸ ³úÁúȯ¿¬±¸È¸ ÇмúÀÌ»ç
  • Frontiers in Stroke editorial board
  • BMC Neurology editorial board
  • ´ëÇѳúÁ¹ÁßÇÐȸ ½ÉÀå»öÀü¿¬±¸È¸ ºÎȸÀå
  • ´ëÇѽŰæ°úÇÐȸ ¼ö·ÃÀ§¿øÈ¸ À§¿ø
°íÇ÷¾Ð ±³°ú¼­ °³Á¤ÆÇ
´ëÇ¥¼­Àû

°íÇ÷¾Ð ±³°ú¼­ °³Á¤ÆÇ

  • ÀúÀÚ(±Û)Ç㼺Çõ ¿Ü
  • ÃâÆÇ»ç´ëÇÑÀÇÇÐ
  • ¹ßÇàÀÏ2020³â 11¿ù 05ÀÏ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 5°Ç
Á¦ ¸ñ ³úÁ¹Áß ±³°ú¼­ °³Á¤ÆÇ
ÃâÆÇ»ç ¹ßÇàÀÏ 2015³â
Á¦ ¸ñ ½Å°æ°úÇÐ ±³°ú¼­ °³Á¤ÆÇ
ÃâÆÇ»ç ¹ßÇàÀÏ 2014³â
Á¦ ¸ñ ³úÁ¹Áß ±³°ú¼­
ÃâÆÇ»ç ¹ßÇàÀÏ 2009³â
Á¦ ¸ñ Çѱ¹ ³úÁ¹Áß °¡À̵å¶óÀÎ
ÃâÆÇ»ç ¹ßÇàÀÏ 2009³â
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Causes, Risk Factors, and Clinical Outcomes of Stroke in Korean Young Adults: Systemic Lupus Erythematosus is Associated with Unfavorable Outcomes
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Atherosclerotic plaque locations may be related to different ischemic lesion patterns
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Elevated troponin levels are associated with early neurological worsening in ischemic stroke with atrial fibrillation
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Prediction of deep vein thrombosis by ultrasonography and D-dimer in Asian patients with ischemic stroke
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Early increment of soluble triggering receptor expressed on myeloid cells 2 in plasma might be a predictor of poor outcome after ischemic stroke
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage Subgroup Analysis of the PICASSO Trial
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°æÈñ´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-958-8114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °­Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°­À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.

°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä